Five minutes with . . . Louis Chesler

BMJ 2017; 356 doi: (Published 14 March 2017) Cite this as: BMJ 2017;356:j1304
  1. Anne Gulland
  1. London

The Institute of Cancer Research’s leader in paediatric solid tumour biology and therapeutics explains why children need better access to cancer drug trials

“We commonly come across this problem [inability to get children into drug trials] when a patient relapses with cancer and needs some modern targeted drug. Often the parents are internet savvy and aware that there is a drug trial for adults and will ask for their child to go on it. It generates a lot of frustration and anxiety, and it’s upsetting for paediatricians to have so few choices. …

View Full Text

Sign in

Log in through your institution